81 FR 9483 - Health Insurance MarketplaceSM
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services Federal Register Volume 81, Issue 37 (February 25, 2016)
Centers for Medicare & Medicaid Services
Federal Register Volume 81, Issue 37 (February 25, 2016)
| Page Range | 9483-9485 | |
| FR Document | 2016-04091 |
[Federal Register Volume 81, Number 37 (Thursday, February 25, 2016)] [Notices] [Pages 9483-9485] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-04091] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS-7040-N] Health Insurance Marketplace\SM\, Medicare, Medicaid, and the Children's Health Insurance Program; Meeting of the Advisory Panel on Outreach and Education (APOE) AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice of meeting. ----------------------------------------------------------------------- SUMMARY: This notice announces the new meeting of the Advisory Panel on Outreach and Education (APOE) (the Panel) in accordance with the Federal Advisory Committee Act. The Panel advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on opportunities to enhance the effectiveness of Health Insurance Marketplace\SM\,\1\ Medicare, Medicaid, and Children's Health Insurance Program (CHIP) consumer education strategies. This meeting is open to the public. --------------------------------------------------------------------------- \1\ Health Insurance Marketplace\SM\ and Marketplace\SM\ are service marks of the U.S. Department of Health & Human Services. DATES: Meeting Date: Wednesday, March 23, 2016, 8:30 a.m. to 4:00 p.m. eastern daylight time (e.d.t.). Deadline for Meeting Registration, Presentations, Special Accommodations and Comments: Wednesday, March 9, 2016, 5:00 p.m., eastern standard time (e.s.t.). ADDRESSES: Meeting Location: U.S. Department of Health & Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., Room 425A, Conference Room, Washington, DC 20201. Presentations and Written Comments: Presentations and written comments should be submitted to: Abigail Huffman, Designated Federal Official (DFO), Division of Forum and Conference Development, Office of Communications, Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Mailstop S1 05-06, Baltimore, MD 21244 1850 or via email at [email protected]. Registration: The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register at the Web site https://www.regonline.com/apoemar2016meeting or by contacting the DFO as listed in the FOR FURTHER INFORMATION CONTACT section of this notice, by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations should contact the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. FOR FURTHER INFORMATION CONTACT: Abigail Huffman, Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1-05-06, Baltimore, MD 21244, 410-786-0897, email [email protected]. Additional information about the APOE is available on the Internet at: http://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through the CMS Press Office at (202) 690-6145. SUPPLEMENTARY INFORMATION: I. Background The Advisory Panel for Outreach and Education (APOE) (the Panel) is governed by the provisions of Federal Advisory Committee Act (FACA) (Pub. L. 92-463), as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of federal advisory committees. The Panel is authorized by section 1114(f) of the Social Security Act (42 U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 U.S.C. 217a). The Secretary of the U.S. Department of Health and Human Services (HHS) (the Secretary) signed the charter establishing the Citizen's Advisory Panel on Medicare Education \2\ (the predecessor to the APOE) on January 21, 1999 (64 FR 7899, February 17, 1999) to advise and make recommendations to the Secretary and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on the effective implementation of national Medicare education programs, including with respect to the Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997 (Pub. L. 105-33). --------------------------------------------------------------------------- \2\ We note that the Citizens' Advisory Panel on Medicare Education is also referred to as the Advisory Panel on Medicare Education (65 FR 4617). The name was updated in the Second Amended Charter approved on July 24, 2000. --------------------------------------------------------------------------- The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108-173) expanded the existing health plan options and benefits available under the M+C program and renamed it the Medicare Advantage (MA) program. We have had substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options available and better tools to evaluate these options. The successful MA program implementation required CMS to consider the views and policy input from a variety of private sector constituents and to develop a broad range of public-private partnerships. In addition, Title I of the MMA authorized the Secretary and the Administrator of CMS (by delegation) to establish the Medicare prescription drug benefit. The drug benefit allows beneficiaries to obtain qualified prescription drug coverage. In order to effectively administer the MA program and the Medicare prescription drug benefit, we have substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options and benefits available, and to develop better tools to evaluate these plans and benefits. The Affordable Care Act (Patient Protection and Affordable Care Act, Pub. L. 111-148, and Health Care and Education Reconciliation Act of 2010, Pub. L. 111-152) expanded the availability of other options for health care coverage and enacted a number of changes to Medicare as well as to Medicaid and the Children's Health Insurance Program (CHIP). Qualified individuals and qualified employers are [[Page 9484]] now able to purchase private health insurance coverage through competitive marketplaces, called Affordable Insurance Exchanges (we also call an Exchange a Health Insurance Marketplace\SM\ or Marketplace\SM\). In order to effectively implement and administer these changes, we must provide information to consumers, providers, and other stakeholders through education and outreach programs regarding how existing programs will change and the expanded range of health coverage options available, including private health insurance coverage through a Marketplace\SM\. The APOE (the Panel) allows us to consider a broad range of views and information from interested audiences in connection with this effort and to identify opportunities to enhance the effectiveness of education strategies concerning the Affordable Care Act. The scope of this panel also includes advising on issues pertaining to the education of providers and stakeholders with respect to the Affordable Care Act and certain provisions of the Health Information Technology for Economic and Clinical Health (HITECH) Act enacted as part of the American Recovery and Reinvestment Act of 2009 (ARRA). On January 21, 2011, the Panel's charter was renewed and the Panel was renamed the Advisory Panel for Outreach and Education. The Panel's charter was most recently renewed on January 21, 2015, and will terminate on January 21, 2017 unless renewed by appropriate action. Under the current charter, the APOE will advise the Secretary and the Administrator on optimal strategies for the following:Developing and implementing education and outreach programs for individuals enrolled in, or eligible for, Medicare, Medicaid, and the Children's Health Insurance Program (CHIP), or coverage available through a Health Insurance Marketplace\SM\. Enhancing the federal government's effectiveness in informing Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP consumers, issuers, providers, and stakeholders, through education and outreach programs, on issues regarding these programs, including the appropriate use of public-private partnerships to leverage the resources of the private sector in educating beneficiaries, providers, and stakeholders. Expanding outreach to vulnerable and underserved communities, including racial and ethnic minorities, in the context of Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP education programs. Assembling and sharing an information base of ``best practices'' for helping consumers evaluate health coverage options. Building and leveraging existing community infrastructures for information, counseling, and assistance. Drawing the program link between outreach and education, promoting consumer understanding of health care coverage choices, and facilitating consumer selection/enrollment, which in turn support the overarching goal of improved access to quality care, including prevention services, envisioned under the Affordable Care Act. The current members of the Panel are: Kellan Baker, Associate Director, Center for American Progress; Robert Blancato, President, Matz, Blancato & Associates; Dale Blasier, Professor of Orthopedic Surgery, Department of Orthopedics, Arkansas Children's Hospital; Deborah Britt, Executive Director of Community & Public Relations, Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of Pediatrics & Public Health, The Ohio State University, Nationwide Children's Hospital; Josephine DeLeon, Director, Anti-Poverty Initiatives, Catholic Charities of California; Robert Espinoza, Vice President of Policy, Paraprofessional Healthcare Institute; Jennifer Gross, Manager of Political Field Operations, Planned Parenthood of Montana; Louise Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Miriam Mobley-Smith, Director of Strategic Alliances, Pharmacy Technician Certification Board; Roanne Osborne-Gaskin, M.D., Senior Medical Director, MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation Support, Independent Contractor; Brendan Riley, Outreach and Enrollment Coordinator, NC Community Health Center Association; Jeanne Ryer, Director, New Hampshire Citizens Health Initiative, University of New Hampshire; Alvia Siddiqi, Medicaid Managed Care Community Network (MCCN) Medical Director, Advocate Physician Partners, Carla Smith, Executive Vice President, Healthcare Information and Management Systems Society (HIMSS); Tobin Van Ostern, Vice President and Co-Founder, Young Invincible Advisors; and Paula Villescaz, Senior Consultant, Assembly Health Committee, California State Legislature. II. Meeting Agenda In accordance with section 10(a) of the FACA, this notice announces a meeting of the APOE. The agenda for the March 23, 2016 meeting will include the following: Welcome and listening session with CMS leadership Recap of the previous (January 13, 2016) meeting Affordable Care Act initiatives An opportunity for public comment Meeting summary, review of recommendations, and next steps Individuals or organizations that wish to make a 5-minute oral presentation on an agenda topic should submit a written copy of the oral presentation to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. The number of oral presentations may be limited by the time available. Individuals not wishing to make a presentation may submit written comments to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. III. Security, Building, and Parking Guidelines This meeting will be held in a federal government building; therefore, federal security measures are applicable. The Real ID Act, enacted in 2005, establishes minimum standards for the issuance of state-issued driver's licenses and identification (ID) cards. It prohibits Federal agencies from accepting an official driver's license or ID card from a state unless the Department of Homeland Security determines that the state meets these standards. Beginning October 2015, photo IDs (such as a valid driver's license) issued by a state or territory not in compliance with the Real ID Act will not be accepted as identification to enter Federal buildings. Visitors from these states/territories will need to provide alternative proof of identification (such as a valid passport) to gain entrance into CMS buildings. The current list of states from which a Federal agency may accept driver's licenses for an official purpose is found at http://www.dhs.gov/real-id-enforcement-brief. We recommend that confirmed registrants arrive reasonably early, but no earlier than 45 minutes prior to the start of the meeting, to allow additional time to clear security. Security measures include the following: Presentation of government issued photographic identification to the Federal Protective Service or Guard Service personnel. [[Page 9485]] Inspection of vehicle's interior and exterior (this includes engine and trunk inspection) at the entrance to the grounds. Parking permits and instructions will be issued after the vehicle inspection. Inspection, via metal detector or other applicable means, of all persons entering the building. We note that all items brought into CMS, whether personal or for the purpose of presentation or to support a presentation, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set up, safety, or timely arrival of any personal belongings or items used for presentation or to support a presentation. Note: Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. The public may not enter the building earlier than 45 minutes prior to the convening of the meeting. All visitors must be escorted in areas other than the lower and first floor levels in the Central Building. Authority: Sec. 222 of the Public Health Service Act (42 U.S.C. 217a) and sec. 10(a) of Pub. L. 92-463 (5 U.S.C. App. 2, sec. 10(a) and 41 CFR 102-3). Dated: February 18, 2016. Andrew M. Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2016-04091 Filed 2-24-16; 8:45 am] BILLING CODE 4120-01-P
![Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices 9483
public comments on four separate strategies. This meeting is open to the authorized by section 1114(f) of the
information collection requests. public. Social Security Act (42 U.S.C. 1314(f))
Through the publication of this DATES: and section 222 of the Public Health
correction document, we are notifying Meeting Date: Wednesday, March 23, Service Act (42 U.S.C. 217a).
the public that we are no longer 2016, 8:30 a.m. to 4:00 p.m. eastern The Secretary of the U.S. Department
requesting or accepting public daylight time (e.d.t.). of Health and Human Services (HHS)
comments on the information collection Deadline for Meeting Registration, (the Secretary) signed the charter
request that published on Wednesday, Presentations, Special Accommodations establishing the Citizen’s Advisory
February 10, 2016 (81 FR 7124), and is and Comments: Wednesday, March 9, Panel on Medicare Education 2 (the
titled ‘‘Medicare Prior Authorization of 2016, 5:00 p.m., eastern standard time predecessor to the APOE) on January 21,
Home Health Services Demonstration.’’ (e.s.t.). 1999 (64 FR 7899, February 17, 1999) to
Form number: CMS–10599 (OMB advise and make recommendations to
ADDRESSES:
control number: 0938—New). All public Meeting Location: U.S. Department of the Secretary and the Administrator of
comments regarding CMS–10599 should Health & Human Services, Hubert H. the Centers for Medicare & Medicaid
be submitted via the instructions listed Services (CMS) on the effective
Humphrey Building, 200 Independence
in the original notice. The original implementation of national Medicare
Avenue SW., Room 425A, Conference
notice for CMS–10599 published on education programs, including with
Room, Washington, DC 20201.
Friday, February 5, 2016 (81 FR 6275). Presentations and Written Comments: respect to the Medicare+Choice (M+C)
The original 60-day comment period for Presentations and written comments program added by the Balanced Budget
the notice that published on February 5, should be submitted to: Abigail Act of 1997 (Pub. L. 105–33).
2016 (81 FR 6275) remains in effect and The Medicare Modernization Act of
Huffman, Designated Federal Official
ends on April 5, 2016. 2003 (MMA) (Pub. L. 108–173)
(DFO), Division of Forum and
expanded the existing health plan
Dated: February 19, 2016. Conference Development, Office of
options and benefits available under the
William N. Parham, III, Communications, Centers for Medicare M+C program and renamed it the
Director, Paperwork Reduction Staff, Office & Medicaid Services, 7500 Security Medicare Advantage (MA) program. We
of Strategic Operations and Regulatory Boulevard, Mailstop S1 05–06, have had substantial responsibilities to
Affairs. Baltimore, MD 21244 1850 or via email provide information to Medicare
[FR Doc. 2016–03922 Filed 2–24–16; 8:45 am] at Abigail.Huffman1@cms.hhs.gov. beneficiaries about the range of health
Registration: The meeting is open to
BILLING CODE 4120–01–P plan options available and better tools
the public, but attendance is limited to
to evaluate these options. The
the space available. Persons wishing to successful MA program implementation
DEPARTMENT OF HEALTH AND attend this meeting must register at the required CMS to consider the views and
HUMAN SERVICES Web site https://www.regonline.com/ policy input from a variety of private
apoemar2016meeting or by contacting sector constituents and to develop a
Centers for Medicare & Medicaid the DFO as listed in the FOR FURTHER broad range of public-private
Services INFORMATION CONTACT section of this
partnerships.
notice, by the date listed in the DATES In addition, Title I of the MMA
[CMS–7040–N] section of this notice. Individuals authorized the Secretary and the
requiring sign language interpretation or Administrator of CMS (by delegation) to
Health Insurance MarketplaceSM, other special accommodations should establish the Medicare prescription drug
Medicare, Medicaid, and the Children’s contact the DFO at the address listed in benefit. The drug benefit allows
Health Insurance Program; Meeting of the ADDRESSES section of this notice by beneficiaries to obtain qualified
the Advisory Panel on Outreach and the date listed in the DATES section of prescription drug coverage. In order to
Education (APOE) this notice. effectively administer the MA program
FOR FURTHER INFORMATION CONTACT: and the Medicare prescription drug
AGENCY: Centers for Medicare & Abigail Huffman, Designated Federal benefit, we have substantial
Medicaid Services (CMS), HHS. Official, Office of Communications, responsibilities to provide information
ACTION: Notice of meeting. CMS, 7500 Security Boulevard, Mail to Medicare beneficiaries about the
Stop S1–05–06, Baltimore, MD 21244, range of health plan options and
SUMMARY: This notice announces the 410–786–0897, email benefits available, and to develop better
new meeting of the Advisory Panel on Abigail.Huffman1@cms.hhs.gov. tools to evaluate these plans and
Outreach and Education (APOE) (the Additional information about the APOE benefits.
Panel) in accordance with the Federal is available on the Internet at: http:// The Affordable Care Act (Patient
Advisory Committee Act. The Panel www.cms.gov/Regulations-and- Protection and Affordable Care Act,
advises and makes recommendations to Guidance/Guidance/FACA/APOE.html. Pub. L. 111–148, and Health Care and
the Secretary of the U.S. Department of Press inquiries are handled through the Education Reconciliation Act of 2010,
Health and Human Services (HHS) and CMS Press Office at (202) 690–6145. Pub. L. 111–152) expanded the
the Administrator of the Centers for SUPPLEMENTARY INFORMATION: availability of other options for health
Medicare & Medicaid Services (CMS) on care coverage and enacted a number of
I. Background changes to Medicare as well as to
opportunities to enhance the
Medicaid and the Children’s Health
mstockstill on DSK4VPTVN1PROD with NOTICES
effectiveness of Health Insurance The Advisory Panel for Outreach and
MarketplaceSM,1 Medicare, Medicaid, Education (APOE) (the Panel) is Insurance Program (CHIP). Qualified
and Children’s Health Insurance governed by the provisions of Federal individuals and qualified employers are
Program (CHIP) consumer education Advisory Committee Act (FACA) (Pub.
2 We note that the Citizens’ Advisory Panel on
L. 92–463), as amended (5 U.S.C.
Medicare Education is also referred to as the
1 Health Insurance MarketplaceSM and Appendix 2), which sets forth standards Advisory Panel on Medicare Education (65 FR
MarketplaceSM are service marks of the U.S. for the formation and use of federal 4617). The name was updated in the Second
Department of Health & Human Services. advisory committees. The Panel is Amended Charter approved on July 24, 2000.
VerDate Sep<11>2014 18:07 Feb 24, 2016 Jkt 238001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\25FEN1.SGM 25FEN1](https://thefederalregister.org/doc/81_FR_9520/page/1.svg)
![Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices 9485
• Inspection of vehicle’s interior and workshop will focus on the standards Center (see ADDRESSES) are eligible for a
exterior (this includes engine and trunk relevant to the qualification of a range reduced rate of $226 per night
inspection) at the entrance to the of safety biomarkers and examine case (equivalent to the government per diem
grounds. Parking permits and studies in several different organ rate), not including applicable taxes. To
instructions will be issued after the systems. receive the reduced rate, follow the Web
vehicle inspection. DATES: The public workshop will be link that will be provided to you upon
• Inspection, via metal detector or held on April 14, 2016, from 9 a.m. to completion of online registration.
other applicable means, of all persons 5 p.m. and April 15, 2016, from 8 a.m. If you need special accommodations
entering the building. We note that all to 5 p.m. due to a disability, please contact
items brought into CMS, whether ADDRESSES: The public workshop will Janelle Lewis (see FOR FURTHER
personal or for the purpose of be held at the Bethesda North Marriott INFORMATION CONTACT) at the Foundation
presentation or to support a Hotel and Conference Center, 5701 for the NIH at least 7 days in advance
presentation, are subject to inspection. Marinelli Rd., Bethesda, MD 20852. of the workshop.
We cannot assume responsibility for Dated: February 19, 2016.
FOR FURTHER INFORMATION CONTACT:
coordinating the receipt, transfer,
Janelle Lewis, Foundation for the Leslie Kux,
transport, storage, set up, safety, or National Institutes of Health, 9650 Associate Commissioner for Policy.
timely arrival of any personal Rockville Pike, Bethesda, MD 20814, [FR Doc. 2016–04027 Filed 2–24–16; 8:45 am]
belongings or items used for 301–594–2919, FAX: 301–480–2752,
presentation or to support a BILLING CODE 4164–01–P
email: jlewis@fnih.org.
presentation.
SUPPLEMENTARY INFORMATION: The need
Note: Individuals who are not registered in for evidentiary standards to qualify DEPARTMENT OF HEALTH AND
advance will not be permitted to enter the biomarkers was identified in FDA’s HUMAN SERVICES
building and will be unable to attend the
Critical Path Initiative as essential to
meeting. The public may not enter the Office of the Secretary
building earlier than 45 minutes prior to the
improving the efficiency and
convening of the meeting. effectiveness of drug development.
Evidentiary standards vary among [Document Identifier: OS–4040–0010 60D]
All visitors must be escorted in areas different types of biomarkers and
other than the lower and first floor according to the context(s) of use (COU) Agency Information Collection
levels in the Central Building. for which qualification is being Activities; Submission to OMB for
Authority: Sec. 222 of the Public Health considered, and there are specific Review and Approval; Public Comment
Service Act (42 U.S.C. 217a) and sec. 10(a) challenges involved in qualifying drug Request
of Pub. L. 92–463 (5 U.S.C. App. 2, sec. 10(a) safety biomarkers. This workshop is
and 41 CFR 102–3). AGENCY: Electronic Government Office,
aimed at creating alignment among
HHS.
Dated: February 18, 2016. scientific stakeholders including FDA,
the National Institutes of Health (NIH), ACTION: Notice.
Andrew M. Slavitt,
Acting Administrator, Centers for Medicare the biopharmaceutical industry, SUMMARY: In compliance with section
& Medicaid Services. academic researchers, and patient 3507(a)(1)(D) of the Paperwork
[FR Doc. 2016–04091 Filed 2–24–16; 8:45 am] groups regarding a proposed framework Reduction Act of 1995, the Electronic
BILLING CODE 4120–01–P
for determining the levels of evidence Government Office (EGOV), Department
required to qualify biomarkers for use in of Health and Human Services, has
drug development, with an emphasis on submitted an Information Collection
DEPARTMENT OF HEALTH AND biomarkers used in determinations of Request (ICR), described below, to the
HUMAN SERVICES drug safety assessments. Development Office of Management and Budget
of a general framework for biomarker (OMB) for review and approval. The ICR
Food and Drug Administration qualification will be discussed, along is for a 3-year extension for OMB
with specific application to different Control Number 4040–0010. The ICR
[Docket No. FDA–2016–N–0001]
COUs related to drug safety, including will expire on September 30, 2016. The
Developing an Evidentiary Standards consideration of several specific case 4040–0010 is composed of the following
Framework for Safety Biomarkers studies involving qualification of forms: Project Abstract; Project
Qualification; Public Workshop clinical markers of toxicity in different Performance Site Location(s); and Key
organ systems. Contacts. The ICR also requests
AGENCY: Food and Drug Administration, Registration: There is no fee to attend
categorizing these forms as common
HHS. the workshop, but attendees must
forms, meaning HHS will only request
ACTION: Notice of public workshop. register in advance. Space is limited,
approval for its own use of the form
and registration will be on a first-come,
SUMMARY: The Food and Drug rather than aggregating the burden
first-served basis. Persons interested in
Administration (FDA), in co- estimate across all Federal Agencies as
attending this workshop must register
sponsorship with the Foundation for the was done for previous actions on this
online at www.fnih.org/
National Institutes of Health Biomarkers OMB control number. Comments
evidentiarystandardsworkshop by April
Consortium (FNIH BC), is announcing a submitted during the first public review
1, 2016. For those persons without
of this ICR will be provided to OMB.
mstockstill on DSK4VPTVN1PROD with NOTICES
public workshop entitled ‘‘Developing Internet access, please contact Janelle
an Evidentiary Standards Framework for OMB will accept further comments from
Lewis at the Foundation for the NIH (see
Safety Biomarkers Qualification the public on this ICR during the review
FOR FURTHER INFORMATION CONTACT) to
Workshop.’’ The purpose of the and approval period.
register.
workshop is to discuss the evidentiary Attendees are responsible for their DATES: Comments on the ICR must be
standards needed to support biomarker own hotel accommodations. Attendees received on or before April 25, 2016.
qualification with a particular emphasis making reservations at the Bethesda ADDRESSES: Submit your comments to
on drug safety markers. The 2-day North Marriott Hotel and Conference ed.calimag@hhs.gov or (202) 690–7569.
VerDate Sep<11>2014 18:07 Feb 24, 2016 Jkt 238001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\25FEN1.SGM 25FEN1](https://thefederalregister.org/doc/81_FR_9520/page/3.svg)
Document Created: 2018-02-02 14:35:26
Document Modified: 2018-02-02 14:35:26
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of meeting. | |
| Dates | Meeting Date: Wednesday, March 23, 2016, 8:30 a.m. to 4:00 p.m. eastern daylight time (e.d.t.). | |
| Contact | Abigail Huffman, Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1-05-06, Baltimore, MD 21244, 410-786-0897, email [email protected] Additional information about the APOE is available on the Internet at: http://www.cms.gov/Regulations-and- Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through the CMS Press Office at (202) 690-6145. | |
| FR Citation | 81 FR 9483 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR